Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients

Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients

Background: We investigated the efficacy, safety and tolerability of once-monthly administration of C.E.R.A. in erythropoiesis stimulating agents (ESAs) naive predialysis patients with CKD for anemia treatment Study Design: Single arm, open label study. Methods: A total of 75 patients (mean (S...

Full description

Bibliographic Details
Main Authors: Sedat Üstündağ, Ekrem Doğan, Murat Duranay, Rümeyza Kazancıoğlu, Vedat Çelik, Abdülkadir Ünsal, Lütfullah Altıntepe, Belda Dursun, Ertuğrul Akbaş, Alaattin Yıldız
Format: Article
Language:English
Published: Galenos Publishing House 2016-06-01
Series:Balkan Medical Journal
Subjects:
C.E.R.A.
chronic kidney disease
efficacy
hemoglobin levels
safety
tolerability
Online Access:http://balkanmedicaljournal.org/text.php?lang=en&id=127

Internet

http://balkanmedicaljournal.org/text.php?lang=en&id=127

Similar Items